Type Here to Get Search Results !

Maternal & Newborn Health - Antepartum - 6528

Incorrect
Correct Answer(s): C

A. “Chorionic Villous Sampling (CVS) may detect neural tube defects.”

[28%]

B. “Maternal serum alpha-fetal protein (MSAFP) may determine the sex of the baby.”

[5%]

C. “Amniocentesis may be used to assess for chromosomal abnormalities.”

[57%]

D. “A biophysical profile (BPP) assesses six variables such as fetal glucose.”

[10%]

Statistics

Difficulty level - Medium
57%of peers got it right
Time taken - 2 s

Subject/Lesson

  • Subject

    Maternal & Newborn Health
  • Lesson

    Antepartum

Client Need

  • Test Plan

    Health Promotion and Maintenance
  • Related Topic

    Ante/Intra/Postpartum and Newborn Care

Item Type

  • Item Type

    Knowledge/Comprehension

Explanation

Choice C is correct. Amniocentesis is a widely used antepartum test that may determine the sex of a fetus, the presence of neural tube defects, chromosomal abnormalities, and fetal lung maturity. This test may also be used therapeutically for polyhydramnios, as it may remove some excessive amniotic fluid volumes.

Choice A is incorrect. CVS is a test that may be performed as early as week ten to determine if the fetus has any chromosomal abnormalities, not neural tube defects.

Choice B is incorrect. MSAFP is a test that assesses neural tube defects, not sex. This test is a blood draw from the client and is done between 15 and 20 gestational weeks.

Choice D is incorrect. A BPP considers five variables, and fetal glucose is not one of them. Aspects assessed in a BPP include fetal breathing movements, fetal movements, fetal tone, amniotic fluid index, and fetal heart rate patterns via a nonstress test.

Additional Info

Last Updated - 20 Jul 2025